Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...
Pharmaceutical companies have already raised the price of over 800 brand-name prescription drugs this year. Nearly all the ...
With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.
On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs ...
Demand slipped for several large contract research organizations last year, and a new report from William Blair analysts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback